Sarepta Therapeutics (SRPT) Shares Repurchased: 2011-2025
Historic Shares Repurchased for Sarepta Therapeutics (SRPT) over the last 9 years, with Sep 2025 value amounting to $16.4 million.
- Sarepta Therapeutics' Shares Repurchased fell 66.54% to $16.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $309.7 million, marking a year-over-year increase of 58.27%. This contributed to the annual value of $205.1 million for FY2024, which is 12.39% up from last year.
- Latest data reveals that Sarepta Therapeutics reported Shares Repurchased of $16.4 million as of Q3 2025, which was down 60.60% from $41.6 million recorded in Q2 2025.
- In the past 5 years, Sarepta Therapeutics' Shares Repurchased registered a high of $205.1 million during Q4 2024, and its lowest value of $16.4 million during Q3 2025.
- Moreover, its 3-year median value for Shares Repurchased was $46.6 million (2025), whereas its average is $58.4 million.
- Per our database at Business Quant, Sarepta Therapeutics' Shares Repurchased surged by 347.63% in 2024 and then slumped by 66.54% in 2025.
- Sarepta Therapeutics' Shares Repurchased (Quarterly) stood at $29.8 million in 2021, then surged by 69.60% to $50.5 million in 2022, then declined by 9.27% to $45.8 million in 2023, then skyrocketed by 347.63% to $205.1 million in 2024, then tumbled by 66.54% to $16.4 million in 2025.
- Its Shares Repurchased stands at $16.4 million for Q3 2025, versus $41.6 million for Q2 2025 and $46.6 million for Q1 2025.